Experience

As a clinical monitor I am familiar with the evaluation, initiation, monitoring and close-out of clinical sites in various indications and types:

Neurology:

restless-legs-syndrome (phase 3), insomnia (phase 2), Alzheimer`s disease (phase 2), migraine (phase 3), smoking withdrawal (phase 4)

Pneumology:

infectious diseases (phase 1), allergic rhinitis (phase 1), asthma & COPD (phases 2 – 4)

Orthopedia:

osteoarthritis knee (phase 2), rheumatoid arthrosis (phase 2), osteoporosis (phase 2), prophylaxis of deep vein thrombosis (phase 2)

Urology:

obstipation (phase 1), benign prostate hyperplasia (phase 3), overactive bladder (phase 3), erectile dysfunction (phases 3 – 4)

CV:

hypertension (phase 1), coronary heart disease (phase 2), dyslipidemia (phase 2)

Oncology:

renal cell carcinoma (phase 3), interstitial cell carcinoma (phase 3)

Vaccines:

sternal wound infection (phase 2), herpes zoster (phase 3)

Furthermore my experience includes monitoring of electronic CRFs such as InForm, Rave, RDE, RDMI, randomization systems as IVRS, ICON, RAMOS, tracking systems as CTMS and eTrack as well as handling of electronic devices from PHT, Invivo, eRT and Hertford Cardiology companies.

One of my strengths is training and development of new monitors. Additionally I have theoretical and practical experience in the management of special projects regarding the optimization of study recruitment and cooperation between clinical research and sales force.